Adalimumab for Rheumatoid Arthritis?

Ebell, Mark; Kripke, Clarissa
February 2006
American Family Physician;2/1/2006, Vol. 73 Issue 3, p435
Academic Journal
Answers a question on the safety and effectiveness of adalimumab (Humira) for rheumatoid arthritis. Required dosage of adalimumab; Effectiveness of the combination of adalimumab with methotrexate; Indications for adalimumab.


Related Articles

  • Wie wirksam ist Rituximab bei der rheumatoiden Arthritis? Schmidt, W. A.; Schicke, B.; Krause, A.; Wernicke, D. // Zeitschrift für Rheumatologie;Jun2010, Vol. 69 Issue 4, p349 

    Does experience with rituximab treatment of rheumatoid arthritis (RA) in daily clinical practice confirm the results of controlled randomized studies? This is a retrospective data-analysis of the first 50 patients from one center with rituximab treatment for RA. The patients received at least...

  • Prevalence of dermatophytosis in patients with rheumatoid arthritis. Bicer, Ali; Tursen, Umit; Cimen, Ozlem Bolgen; Kaya, Tamer Irfan; Ozisik, Sacettin; Ikizoglu, Guliz; Erdogan, Canan // Rheumatology International;Jan2003, Vol. 23 Issue 1, p37 

    Objective. The prevalence of dermatophytic infections in rheumatoid arthritis is unknown. This study investigated the prevalence of dermatophytosis in patients with rheumatoid arthritis and the relationship between sulfasalazine, low-dose methotrexate and steroid therapy. Methods. We examined 53...

  • Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients. Parker, Benjamin // Current Medical Literature: Rheumatology;2013, Vol. 32 Issue 2, p48 

    The author comments on the paper "Rituximab Dissociates the Tight Link Between Disease Activity and Joint Damage in Rheumatoid Arthritis Patients," by D. Aletaha and colleagues, published in "Annals of the Rheumatic Diseases." Results of the study showed that rituximab, in combination with...

  • The patient-based outcome of upper-extremity surgeries using the DASH questionnaire and the effect of disease activity of the patients with rheumatoid arthritis. Ishikawa, Hajime; Murasawa, Akira; Nakazono, Kiyoshi; Abe, Asami; Otani, Hiroshi; Netsu, Tahahiro; Sakai, Takehito; Sato, Hiroe // Clinical Rheumatology;Aug2008, Vol. 27 Issue 8, p967 

    The Disabilities of the Arm, Shoulder and Hand (DASH) is a standardized patient-based outcome measure, which assesses integrated upper-extremity disorders. The objectives of this study were to investigate subjective outcome after upper-extremity surgeries for the patients with rheumatoid...

  • White cells count in smokers affected by rheumatic diseases. Bartolone, Sebastiano; Calzavara, Emilse; Russo, Giuseppina; Carnì, Antonio; Mannucci, Carmen; Pieratti, Antonella; Caputi, Achille; Calapai, Gioacchino // Rheumatology International;Jan2012, Vol. 32 Issue 1, p109 

    Evidence shows that tobacco smoking interacts with development of rheumatic diseases. Increase in white cells count (leukocytosis) is frequently present, and in smokers, it is considered a biomarker of cardiovascular risk. Aim of the study is to evaluate this biomarker in smokers with rheumatic...

  • Need to Avoid Handshakes. Kellery, Kay // Arthritis Today;Mar/Apr2008, Vol. 22 Issue 2, p12 

    The article seeks advice for dealing with the hand-shaking experienced by her daughter who was diagnosed with rheumatoid arthritis. The shaking of the hands can be extremely painful and the patient does not want to appear rude or call attention to her condition.

  • The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients. Chung, Cecilia P.; Russell, Anthony S.; Segami, Maria I.; Ugarte, César A. // Rheumatology International;Mar2005, Vol. 25 Issue 2, p114 

    Objective: The aim of this study was to determine the difference between bone mineral density (BMD) of rheumatoid arthritis (RA) patients on low-dose prednisone and matched RA patients without prior systemic corticosteroid therapy. Methods: Ninety patients attending our clinics and receiving 10...

  • New developments in ochronosis: review of the literature. Keller, Julie M.; Macaulay, William; Nercessian, Ohannes A.; Jaffe, Israeli A. // Rheumatology International;Mar2005, Vol. 25 Issue 2, p81 

    Ochronosis commonly affects all connective tissue. Recognition of changes secondary to the deposition of ochronotic pigments has increased with advances in diagnostic technology, allowing both improved imaging and early biochemical and genetics-based diagnosis of alkaptonuria, the cause of...

  • Adalimumab provides "clinically important" HRQOL gains in RA.  // PharmacoEconomics & Outcomes News;12/3/2005, Issue 492, p13 

    The article presents information on a study conducted on the benefits of adalimumab to patients with severe, reactive rheumatoid arthritis. The results of the study were presented at the 8th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research which...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics